Activase


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Activase - a thrombolytic agent (trade name Activase) that causes fibrinolysis at the site of a blood clotActivase - a thrombolytic agent (trade name Activase) that causes fibrinolysis at the site of a blood clot; used in treating acute myocardial infarction
clot buster, thrombolytic, thrombolytic agent - a kind of pharmaceutical that can break up clots blocking the flow of blood to the heart muscle
brand, brand name, marque, trade name - a name given to a product or service
References in periodicals archive ?
Assess products, including these: -- Plavix -- Lovenox -- Xarelto -- Pradaxa -- Activase -- Effient -- Aspirin Cardio -- Pletal.
Having been approved by over 85 countries in the world, actilyse is marketed by Boehringer- Ingelheim AG in areas outside North America and Japan, by Genentech under the trade name of Activase since 1996 in the US and by Roche since 1999 in the Canada.
Christie Artuso, the director of Neuroscience Services for Providence Alaska Medical Center, says the drug is called Activase and is the only such drug approved by the FDA for use in dissolving blood clots.
Heat unravels the activase protein, and when it does, the result is a less bountiful harvest.
Heat literally unravels the activase protein, and when it does, the result is a less bountiful harvest.
DVT can be diagnosed with ultrasound and treated, if a specialist prescribes it, with a clot-busting drug such as Activase injected directly into the clot during hospitalization.
Thrombolytics currently on the market such as Abbokinase or Activase are plasminogen activators which rely on the plasminogen system to degrade fibrin.
At the time, Activase was administered only after a heart attack due to the "treacherous" risks attendant to the use of the drug prior to a heart attack.
Cathflow(TM) Activase(R) (Alteplase): Reported positive results of a large-scale Phase III study of safety of Cathflow Activase for treatment of occluded central venous catheters.
Trade-named Activase, tPA is effective only against these so-called ischemic strokes; it cannot help someone with a stroke caused by a hemorrhage.
At the time of the Genentech-Roche link-up, Wall Street's torrid love affair with biotech bad cooled and Genentech was concerned about a shrinking market for Activase, its flagship anti-clotting agent used to treat heart-attack victims.